“marinus-pharmaceuticals” Archives

in
Entry Author Date Location
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug 09/30/20 New York
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take 03/19/19 Boston
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Marinus Claims Phase 2 Postpartum Depression Win, Analysts Less Sure 12/10/18 Boston
As ReVision Raises $55M, Domain’s Dovey Assesses Rusnano Gambit 07/30/13 San Diego
East Coast Life Sciences Roundup: Blend, Amicus, Vertex, & More 12/21/12 Boston
Domain-Rusnano Partnership Invests $93 Million in Three Biotechs 12/19/12 San Diego
Marinus Pharmaceuticals Lands $11,435,690 New Financing Round 12/18/12 Boston
U.S. Venture Funding Plummets (Yada Yada), But New England Less So—Region’s Top 10 Deals of Q1 04/20/09 Boston
A123Systems Counts to $69M, Sun Catalytix Out to Grow Seed From Polaris, Synageva Gets $30M, & More Boston-Area Deals News 04/17/09 Boston
Biogen and Icahn Duel Again, Marinus Gets $20M, Vigilance Urged on Patent Reform, & More Boston-Area Life Sciences News 04/15/09 Boston
Marinus Pharma Finds $20M in 2nd Round 04/13/09 Boston
Marinus Pharmaceuticals Secures $20,000,000 Series B Funding Round 04/10/09 Boston
Page 1 of 1